GAMMA Investing’s Xeris Biopharma Holdings XERS Stock Holding History

GAMMA Investing’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2K	Buy	209 +99	+90%	+$836	﹤0.01%	3953
2026 Q2	$871	Buy	110 +10	+10%	+$64	﹤0.01%	3908
2026 Q1	$580	Buy	100 +77	+335%	+$511	﹤0.01%	3925
2025 Q4	$181	Sell	23 -1	-4%	-$8	﹤0.01%	4004
2025 Q3	$195	Buy	+24	New	+$159	﹤0.01%	3803

Other funds holding XERS

VFP

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's XERS Position: Q3 2026 in Review

GAMMA Investing increased its Xeris Biopharma Holdings (XERS) stake by 90% in Q3 2026, buying an estimated $836 and bringing the position to 209 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3953.

GAMMA Investing first reported a position in XERS in Q3 2025 and has held it in 5 quarters since. 7 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

GAMMA Investing held 209 shares of Xeris Biopharma Holdings worth $2K as of Q3 2026.
GAMMA Investing bought 99 Xeris Biopharma Holdings shares in Q3 2026, an estimated $836.
Xeris Biopharma Holdings made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3953 holding.
GAMMA Investing first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 5 quarters since.
7 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.